Upcoming Events

webIMarS – Australia

webIMarS – Australia

February 12, 2025 - Virtual

The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies. These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.

On February 12, 2025 the IMS and Myeloma Australia will co-host a 90-minute complimentary webinar for healthcare professionals who actively treat patients with multiple myeloma in Australia.

Program

Educational Workshop Johannesburg, South Africa

Educational Workshop Johannesburg, South Africa

February 28 - March 1, 2025 - Radisson Hotel & Convention Centre, Johannesburg, South Africa

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

6th Immune Effector Cell Therapies in Multiple Myeloma Workshop

6th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 28 - 29, 2025 - Boston Marriott Long Wharf, Boston, MA

IMS is pleased to announce that the 6th Annual Immune Effector Cell Therapies in Multiple Myeloma Workshop will take place from March 28-29, 2025 in Boston, MA.

More details will be available soon! 

Educational Workshop Marrakech, Morocco

Educational Workshop Marrakech, Morocco

April 25 - 26, 2025 - Radisson Blu Hotel, Marrakech Carre Eden

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

22nd IMS Annual Meeting

22nd IMS Annual Meeting

September 17 - 20, 2025 - Toronto, Canada

Mark your calendars for the 22nd IMS Annual Meeting in Toronto, Canada.

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.

More details about this meeting will be shared soon.

Apply for a Translational Research Award today!

Deadline January 31, 2025

Apply for an IMS Career Development Award!

Deadline January 31, 2025

 

Translational Research Award

Career Development Award

IMS Young Investigator Award

COMING SOON – ARTEMIS

Meet the recipients of the IMS Translational Research Award!

Meet the recipients of the IMS Career Development Award!

About Our Publications

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

See All Publications

Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events